ArticleInternational journal of obesity (2005)2017

Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system.

K Kaineder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.